Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
Blow-dry brushes may seem like a new invention, but they’ve actually been around since the ’80s. While the blow-dry brushes of the past were cumbersome, today’s iterations are more ...
Foreign Minister Gideon Sa’ar says ‘extreme anti-Israel policy’ of Irish government behind decision To continue reading, we just need a few details ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback